Información del artículo
El Texto completo está disponible en PDF
Bibliografía y lecturas recomendadas
[1.]
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular, Care.
Circulation, 112 (2005), pp. IV1-IV203
[2.]
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Part, 7., 1: Adjuncts for airway Control and Ventilation.
Circulation, 112 (2005),
[3.]
M.J. Kellum, K.W. Kennedy, G.A. Ewy.
Cardiocerebral resuscitation improves survival of patients with out-of-hospital cardiac arrest.
Am J Med, 119 (2006), pp. 335-340
[4.]
M.J. Kellum, K.W. Kennedy, R. Barney, et al.
Cardiocerebral resuscitation improves neurologically intact survival of patients with out-of-hospital cardiac arrest.
Ann Emerg Med, 52 (2008), pp. 244-252
[5.]
M.L. Weisfeldt, L.B. Becker.
Resuscitation after cardiac arrest: a 3-phase time –sensitive model.
JAMA, 288 (2002), pp. 3035-3038
[6.]
A.C. Kenmure, W.R. Murdoch.
Circulatory and metabolic effects of oxygen in myocardial infarction.
Br Med J, 4 (1968), pp. 360-364
[7.]
J. Arnold, S. Goodacre, F. Morris, ESCAPE Research Team.
Structure, process and outcomes of chest pain units established in the ESCAPE trial.
Emerg Med J, 24 (2007), pp. 462-466
[8.]
B.A. Afolabi, G.M. Novaro, S.L. Pinski, K.R. Fromkin, H.S. Bush.
Use of the prehospital ECG improves door-to-ballon times in ST segment elevation myocardial infarction irrespective of time of day or day of week.
Emerg Med J, 24 (2007), pp. 588-591
[9.]
E.M. Antman, H.W. Louwerenburg.
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Circulation, 105 (2002), pp. 1642-1649
[10.]
E.M. Antman, D.A. Morrow, et al.
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
N Engl J Med, 354 (2006), pp. 1477-1488
[11.]
H. White.
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial.
Lancet, 358 (2001), pp. 1855-1863
[12.]
D.L. Bhatt, B.I. Lee, P.J. Casterella, M. Pulsipher, M. Rogers, M. Cohen, et al.
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.
J Am Coll Cardiol, 41 (2003), pp. 20-25
[13.]
V. Campos, J. Herrera, et al.
Decreased total bleeding events with reduced doses of enoxaparin versus unfractionated heparin in high risk unstable angina [Spanish].
Arch Cardiol Mex, 72 (2002), pp. 209-219
[14.]
K.A. Fox, E.M. Antman, G. Montalescot, S. Agewall, B. Soma Raju, F.W. Verheugt.
The impact of renal dysfunction on outcomes in the ExTRACT – TIMI 25 trial.
J Am Coll Cardiol, 49 (2007), pp. 2249-2255
[15.]
G.M. De Luca, et al.
Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty (EGYPT) cooperation An individual patients’ data meta-analysis.
Heart, 94 (2008), pp. 1548-1558
[16.]
S.H. Oshima, et al.
The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Am Heart J, 134 (1997), pp. 961-966
[17.]
A.J. Hjalmarson, et al.
The Goteborg metoprolol trial: effects on mortality and morbidity in acute myocardial infarction.
Circulation, 67 (1983), pp. I26-I32
[18.]
ISIS-1., Mechanism for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction:, ISIS-1.
Lancet, (1988), pp. 921-923
[19.]
W.D. Bussmann, H. Schofer.
Effects of intravenous nitroglycerin on hemodynamics and ischemic injury in patients with acute myocardial infarction.
Eur J Cardiol, 8 (1978), pp. 61-74
[20.]
H. Andersen, T. Nielsen, D. Rasmussen, L. Thuesen, Kelbaek, P. Thayssen, et al.
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
N Engl J Med, 349 (2003), pp. 733-742
[21.]
B.J. Bendz, et al.
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention.
Resuscitation, 63 (2004), pp. 49-53
[22.]
J.K. Kahn, S. Glazier.
Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest.
Am J Cardiol, 75 (1995), pp. 1069-1070
[23.]
C.M. Spaulding, L.M. Joly.
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.
N Engl J Med, 336 (1997), pp. 1629-1633
[24.]
B. Bendz, J. Eritsland, A. Nakstad, M. Brekke, N. Klow, P. Steen, A. Mangschau.
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention.
Resuscitation, 63 (2004), pp. 49-53
[25.]
R. Knafeli, P. Radsel, T. Ploj, M. Noc.
Primary percutaneous coronary intervention and mild induced hypothermia in comatose survivors of ventricular fibrillation with ST-elevation acute myocardial infarction.
Resuscitation, 74 (2007), pp. 227-234
[26.]
C.M. Spaulding, L.M. Joly, A. Rosenberg, M. Monchi, S.N. Weber, J.F. Dhainaut, et al.
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.
N Engl J Med, 336 (1997), pp. 1629-1633
[27.]
P. Garot, T. Lefevre, H. Eltchaninoff, M.C. Morice, F. Tamion, B. Abry, et al.
Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction.
Circulation, 115 (2007), pp. 1354-1362
Copyright © 2010. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular